At Valcare we put Patients first
What is Mitral Valve
Reguritation?
Mitral regurgitation (MR) is a very common type of heart valve disease. With this condition, the mitral valve, which is between the left heart chambers, doesn’t fully close. As a result, blood leaks across the valve.
Mitral valve regurgitation can make you feel very tired or short of breath and can affect your quality of life.
Fixing a leaky heart
valve
Historically, the preferred treatment to restore mitral valve function has been open heart surgery. In most cases, the surgery would involve restoring the valve to its healthy dimensions by implanting a pre-shaped ring.
However, some individuals may not be ideal candidates for open-heart surgery. These patients may benefit from a percutaneous mitral valve repair which is designed to address the backward leakage of blood across your mitral valve to help blood flow properly and may be associated with lower procedural and postoperative complications.
Annuloplasty System
A minimally invasive way to repair the mitral valve
Minimally invasive
The procedure is performed without open-heart surgery, using a small access point.
Inspired by surgery
The system is designed to reshape the valve in a way similar to traditional repair.
Future options
Additional treatments can still be considered later, if needed.
Supports natural function
The goal is to help the valve close properly and improve blood flow.
The Technology behind
the AMEND™ System
The AMEND System is a percutaneous investigational device that is designed to mimic the anatomical reshaping of the mitral valve and clinical results achieved by traditional surgical repair. Unlike other percutaneous mitral repair technologies, the AMEND System is designed to preserve future treatment options if clinically required later.
Videos
This educational video offers a simple overview of the disease and emerging therapies for patients and their families.
Watch Dr. Drew discuss the AMEND System with Dr. Isaac George and Steve Sandweg Valcare’s CEO.
The AMEND TS Early
Feasibility Study (EFS)
The AMEND TS EFS is a prospective, single-arm study to evaluate the AMEND Transseptal System in patients with significant functional mitral regurgitation. The study aims to treat 15 patients and is currently enrolling patients at several investigational sites in the United States.